0001415889-18-001565.txt : 20181031
0001415889-18-001565.hdr.sgml : 20181031
20181031160017
ACCESSION NUMBER: 0001415889-18-001565
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181029
FILED AS OF DATE: 20181031
DATE AS OF CHANGE: 20181031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alles Mark J
CENTRAL INDEX KEY: 0001538897
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 181150248
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
form4-10312018_041001.xml
X0306
4
2018-10-29
0000816284
CELGENE CORP /DE/
CELG
0001538897
Alles Mark J
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
true
true
false
false
CEO, CHAIRMAN OF BOARD
Stock Option (right to buy)
71.43
2018-10-29
4
A
0
59234
0
A
2028-10-29
Common Stock
59234
59234
D
Option is immediately exercisable and will vest in four equal annual installments commencing on October 29, 2019.
The option was issued pursuant to the Company's 2017 Stock Incentive Plan.
/s/ Mark J. Alles
2018-10-31